双侧胸廓内动脉桥通畅患者再次冠状动脉旁路移植术:终身保修之例外
该研究回顾1980年至2020年8108例单纯再次CABG患者,其中91例(1.1%)双侧胸廓内动脉(BITA)桥通畅。所有患者有缺血症状,最常见为不稳定型心绞痛(65例,71%)。再次手术指征包括自体冠状动脉粥样硬化进展(63例,69%)、非BITA桥失败(63例,69%)及BITA桥病变(34例,37%)。手术死亡率为3.3%,中位生存12年。结论认为在经验丰富的中心,此类患者结局良好。
要点
- BITA桥通畅者仅占再次CABG的1.1%,但可因自体血管病变或非BITA桥失败需再次手术。
- 再次手术时仅40%需行LAD bypass,多数患者接受多支血管移植。
- 手术死亡率3.3%,中位生存12年,经验丰富的中心结局良好。
核心结论
- BITA桥通畅患者占再次CABG的1.1%,再次手术指征以自体冠状动脉进展和非ITA桥失败为主,结局良好。
研究设计与样本
- 回顾性分析1980年1月至2020年7月8108例单纯再次CABG患者中91例(1.1%)BITA桥通畅者,平均年龄62±8.7岁,男性81例(89%)。
主要发现
- 所有患者有缺血症状,不稳定型心绞痛65例(71%)。
- 再次手术指征:自体冠状动脉粥样硬化进展63例(69%),非BITA桥失败63例(69%),BITA桥病变34例(37%)。
- 再次手术时使用的桥血管:大隐静脉75例(82%),桡动脉39例(43%),胃网膜动脉8例(8.8%)。
- 靶血管:回旋支58例(64%),右冠状动脉54例(59%),LAD 36例(40%),对角支28例(31%)。
- 手术死亡率3.3%,中位生存12年。
临床怎么用
- 对BITA桥通畅的再次CABG患者,应评估自体冠状动脉病变进展和非BITA桥失败,个体化制定手术策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To undertake an in-depth review of patients undergoing redo coronary artery bypass grafting (CABG) despite patent bilateral internal thoracic artery (BITA) grafts. METHODS: From January 1980 to July 2020, 91 of 8108 patients (1.1%) who underwent isolated redo CABG had patent BITAs. Mean age was 62 ± 8.7 years; 81 (89%) were male. Mean age at previous CABG was 52 ± 9.4 years, with reoperation occurring after a median of 10 years. Indications for reoperation, surgical strategies, and outcomes were analyzed. RESULTS: All patients had ischemic symptoms, most commonly unstable angina (65 [71%]). Anatomic drivers of reoperation included progression of native coronary atherosclerosis (63 [69%]), non-BITA graft failure (63 [69%]), and patent but diseased, atretic, or technically compromised internal thoracic artery grafts (ITAs) (34 [37%]; left: 12, right: 18, bilateral: 4). The left anterior descending artery (LAD) was previously bypassed with an ITA in 78 (86%). At reoperation, conduits used included saphenous vein (75 [82%]), radial artery (39 [43%]), and gastroepiploic artery (8 [8.8%]). Coronary targets included circumflex (58 [64%]), right coronary (54 [59%]), LAD (36 [40%]), and diagonal (28 [31%]) arteries. Operative mortality and median survival were 3.3% and 12 years, respectively. CONCLUSIONS: Patients with patent BITAs represent a small subset of redo CABG cases, with native coronary disease progression and non-ITA graft failure being the most common reoperation indications. Most patients undergo multivessel grafting, with less than one half needing or requiring a bypass to the LAD. Outcomes are good at centers with experienced surgeons.
引用
- Alshneikat M, Ramsingh R, Awad AK, et al. Redo coronary artery bypass grafting in patients with patent bilateral internal thoracic artery grafts: Exceptions to a lifetime warranty. J Thorac Cardiovasc Surg. 2025. PMID: 40684844. doi:10.1016/j.jtcvs.2025.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。